50-167-6122
BTLA Monoclonal Antibody (OTI3D11), TrueMAB™, OriGene
Manufacturer: OriGene
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 50-167-6122-Each-of-1 | In Stock | ₹ 44,954.79 |
50-167-6122 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,954.79
GST (18%): ₹ 8,091.862
Total Price: ₹ 53,046.652
Antigen
BTLA
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
Gene Accession No.
Q7Z6A9
Gene Symbols
BTLA
Immunogen
Full length human recombit protein of human BTLA produced in HEK293T cell.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG2b
Applications
Immunocytochemistry, Immunofluorescence, Western Blot
Clone
OTI3D11
Conjugate
Unconjugated
Gene
BTLA
Gene Alias
BTLA1, CD272
Host Species
Mouse
Purification Method
Affinity Chromatography
Regulatory Status
RUO
Gene ID (Entrez)
151888
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Related Products
Description
- BTLA or B and T-lymphocyte attenuator is a member of the co-inhibitory receptors of the CD28 superfamily
- BTLA is a lymphocyte inhibitory receptor which inhibits lymphocytes during immunes responses
- BTLA is constitutively expressed on most CD4+ and CD8+ T cells and its expression progressively decreases upon T cell activation
- It remains expressed on Th1 cells, but not Th2 cells
- BTLA is a unique co-receptor that interacts with the tumor necrosis factor receptor superfamily member herpesvirus entry mediator (HVEM)
- This interation is an important pathway regulating lymphocyte activation and/or homeostasis in the immune response.